Abstract
No public abstract is available from the verified source records.
Ming-Yu Lin, Yi-Fei Wang, Lin-Lin Zheng, Chang-Zhen Yang, Zhi-Hao Zhao, Xiang-Yu Yan, Si-Qiao Shan, Dong-Liang Yang, Shuo Jin, Jia-Hong Dong
Abstract
Authors
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma
10.1016/j.jhep.2019.03.013 · 2019
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
10.1038/s41575-020-0310-z · 2020
Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors
10.1053/j.gastro.2011.12.005 · 2012
Meta-analysis and Meta-regression of Survival After Liver Transplantation for Unresectable Perihilar Cholangiocarcinoma
10.1097/sla.0000000000003801 · 2021
Recommendations on Perihilar Cholangiocarcinoma. The Milan Jury-Based Consensus
10.1097/sla.0000000000006773 · 2025
10.3322/caac.21388
10.3322/caac.21388
Single-cell transcriptomic analysis suggests two molecularly subtypes of intrahepatic cholangiocarcinoma
10.1038/s41467-022-29164-0 · 2022
Integrative analyses of bulk and single-cell transcriptomics reveals the infiltration and crosstalk of cancer-associated fibroblasts as a novel predictor for prognosis and microenvironment remodeling in intrahepatic cholangiocarcinoma
10.1186/s12967-024-05238-z · 2024
Progression of Metastasis through Lymphatic System
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
datacite
Confidence 0%
10.3390/cells10030627 · 2021
From sewer to saviour - targeting the lymphatic system to promote drug exposure and activity
10.1038/nrd4608 · 2015
Emerging Biological Principles of Metastasis
10.1016/j.cell.2016.11.037 · 2017
Prediction of the lymph node status in patients with intrahepatic cholangiocarcinoma: analysis of 320 surgical cases
10.3389/fonc.2011.00042 · 2011
Development and validation of a novel preoperative clinical model for predicting lymph node metastasis in perihilar cholangiocarcinoma
10.1186/s12885-024-12068-1 · 2024
Immunohistochemically detected expression of p27(Kip1) and Skp2 predicts survival in patients with intrahepatic cholangiocarcinomas
10.1245/s10434-008-0236-0 · 2009
BAP1 acts as a tumor suppressor in intrahepatic cholangiocarcinoma by modulating the ERK1/2 and JNK/c-Jun pathways
10.1038/s41419-018-1087-7 · 2018
Aberrant expression of GATA binding protein 6 correlates with poor prognosis and promotes metastasis in cholangiocarcinoma
10.1016/j.ejca.2012.12.015 · 2013
Genome-wide analysis of gene expression in human intrahepatic cholangiocarcinoma
10.1002/hep.20718 · 2005
Cyclooxygenase-2 is involved in the up-regulation of matrix metalloproteinase-9 in cholangiocarcinoma induced by tumor necrosis factor-alpha
10.2353/ajpath.2009.080012 · 2009
MUC13 promotes intrahepatic cholangiocarcinoma progression via EGFR/PI3K/AKT pathways
10.1016/j.jhep.2019.11.021 · 2020
Cancer metastases: challenges and opportunities
10.1016/j.apsb.2015.07.005 · 2015
TGF-β1 expression is associated with invasion and metastasis of intrahepatic cholangiocarcinoma
10.1186/s40659-015-0016-9 · 2015
Inactivation of Smad4 is a prognostic factor in intrahepatic cholangiocarcinoma
10.3760/cma.j.issn.0366-6999.20121235 · 2013
Upregulation of B7-H4 promotes tumor progression of intrahepatic cholangiocarcinoma
10.1038/s41419-017-0015-6 · 2017
Mitogen-activated protein kinase kinase kinase 4 deficiency in intrahepatic cholangiocarcinoma leads to invasive growth and epithelial-mesenchymal transition
10.1002/hep.28149 · 2015
Serine/threonine kinase TBK1 promotes cholangiocarcinoma progression via direct regulation of β-catenin
10.1038/s41388-023-02651-4 · 2023
MicroRNA-494-dependent WDHDI inhibition suppresses epithelial-mesenchymal transition, tumor growth and metastasis in cholangiocarcinoma
10.1016/j.dld.2018.08.021 · 2019
WDHD1 modulates the post-transcriptional step of the centromeric silencing pathway
10.1093/nar/gkq1338 · 2011
Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma
10.1016/j.jhep.2018.12.004 · 2019
Thrombospondin 1 and 2 along with PEDF inhibit angiogenesis and promote lymphangiogenesis in intrahepatic cholangiocarcinoma
10.1016/j.jhep.2021.07.016 · 2021
Tumor-associated angiogenesis and lymphangiogenesis correlate with progression of intrahepatic cholangiocarcinoma
10.1038/ajg.2009.674 · 2010
Tumor-associated lymphangiogenesis correlates with lymph node metastases and prognosis in hilar cholangiocarcinoma
10.1245/s10434-007-9774-0 · 2008
The biology of vascular endothelial growth factors
10.1016/j.cardiores.2004.12.002 · 2005
Expression of VEGFR-3 in intrahepatic cholangiocarcinoma correlates with unfavorable prognosis through lymphangiogenesis
10.7150/ijbs.26045 · 2018
Dual FGFR and VEGFR inhibition synergistically restrain hexokinase 2-dependent lymphangiogenesis and immune escape in intrahepatic cholangiocarcinoma
10.1007/s00535-023-02012-8 · 2023
High expression of Dickkopf-related protein 1 is related to lymphatic metastasis and indicates poor prognosis in intrahepatic cholangiocarcinoma patients after surgery
10.1002/cncr.27788 · 2013
Lymphatic spread is related to VEGF-C expression and D2-40-positive myofibroblasts in intrahepatic cholangiocarcinoma
10.1038/modpathol.3800985 · 2008
Epithelial-mesenchymal transition in cholangiocarcinoma: From clinical evidence to regulatory networks
10.1016/j.jhep.2016.09.010 · 2017
Myofibroblast-derived PDGF-BB promotes Hedgehog survival signaling in cholangiocarcinoma cells
10.1002/hep.24588 · 2011
Cancer-Associated Fibroblasts Promote Lymphatic Metastasis in Cholangiocarcinoma via the PDGF-BB/PDGFR-β Mediated Paracrine Signaling Network
10.14336/ad.2023.0420 · 2024
Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma
10.1002/hep.26384 · 2013
HNF4α inhibits the malignancy of intrahepatic cholangiocarcinoma by suppressing the Wnt signaling pathway
10.1016/j.tranon.2025.102290 · doi-reference
Correlation between expression of MUC1 core protein and outcome after surgery in mass-forming intrahepatic cholangiocarcinoma
10.1002/cncr.10398 · doi-reference
Tenascin expression at the invasive front is associated with poor prognosis in intrahepatic cholangiocarcinoma
10.1097/01.mp.0000086860.65672.73 · doi-reference
TLR2 promotes human intrahepatic cholangiocarcinoma cell migration and invasion by modulating NF-κB pathway-mediated inflammatory responses
10.1111/febs.13894 · doi-reference
Expression of cytoskeleton-associated protein 4 is related to lymphatic metastasis and indicates prognosis of intrahepatic cholangiocarcinoma patients after surgery resection
10.1016/j.canlet.2013.05.003 · doi-reference
Calcium-sensing receptor promotes tumor proliferation and migration in human intrahepatic cholangiocarcinoma by targeting ERK signaling pathway
10.1016/j.ejphar.2020.172915 · doi-reference
Inositol 1,4,5-trisphosphate receptor type 3 (ITPR3) is overexpressed in cholangiocarcinoma and its expression correlates with S100 calcium-binding protein A4 (S100A4)
10.1016/j.biopha.2021.112403 · doi-reference
c-erbB-2 and c-Met expression relates to cholangiocarcinogenesis and progression of intrahepatic cholangiocarcinoma
10.1046/j.1365-2559.2002.00353.x · doi-reference
CTLA-4 Synergizes With PD1/PD-L1 in the Inhibitory Tumor Microenvironment of Intrahepatic Cholangiocarcinoma
10.3389/fimmu.2021.705378 · doi-reference
TPX2 level correlates with cholangiocarcinoma cell proliferation, apoptosis, and EMT
10.1016/j.biopha.2018.08.011 · doi-reference
Apoptosis-Inducing Factor, Mitochondrion-Associated 3 (AIFM3) Protein Level in the Sera as a Prognostic Marker of Cholangiocarcinoma Patients
10.3390/biom10071021 · doi-reference
Different roles of S100P overexpression in intrahepatic cholangiocarcinoma: carcinogenesis of perihilar type and aggressive behavior of peripheral type
10.1097/pas.0b013e31820ffdf1 · doi-reference
Serum Apurinic/Apyrimidinic Endodeoxyribonuclease 1 (APEX1) Level as a Potential Biomarker of Cholangiocarcinoma
10.3390/biom9090413 · doi-reference
67 laminin receptor promotes the malignant potential of tumour cells up-regulating lysyl oxidase-like 2 expression in cholangiocarcinoma
10.1016/j.dld.2014.03.017 · doi-reference
Unveiling the intratumor microbiome in liver cancer: Current insights and prospective applications
10.3350/cmh.2024.1039 · doi-reference
A pan-cancer analysis of the microbiome in metastatic cancer
10.1016/j.cell.2024.03.021 · doi-reference
Intratumor microbiome features reveal antitumor potentials of intrahepatic cholangiocarcinoma
10.1080/19490976.2022.2156255 · doi-reference
Characterization of tumor microbiome and associations with prognosis in intrahepatic cholangiocarcinoma
10.1007/s00535-024-02090-2 · doi-reference
VIRMA facilitates intrahepatic cholangiocarcinoma progression through epigenetic augmentation of TMED2 and PARD3B mRNA stabilization
10.1007/s00535-023-02015-5 · doi-reference
Yin Yang 1-induced LINC00667 up-regulates pyruvate dehydrogenase kinase 1 to promote proliferation, migration and invasion of cholangiocarcinoma cells by sponging miR-200c-3p
10.1007/s13577-020-00448-1 · doi-reference
LncRNA NEAT1 promotes cell proliferation, migration, and invasion via the miR-186-5p/PTP4A1 axis in cholangiocarcinoma
10.1002/kjm2.12354 · doi-reference
Long Non-coding RNA FOXD2-AS1 Promotes Proliferation, Migration, and Invasion in Cholangiocarcinoma Through Regulating miR-760/E2F3 Axis
10.1007/s10620-021-06876-9 · doi-reference
JUND/linc00976 promotes cholangiocarcinoma progression and metastasis, inhibits ferroptosis by regulating the miR-3202/GPX4 axis
10.1038/s41419-022-05412-5 · doi-reference
Up-regulated LINC00261 predicts a poor prognosis and promotes a metastasis by EMT process in cholangiocarcinoma
10.1016/j.prp.2019.152733 · doi-reference
miR-181b-5p Promotes the Progression of Cholangiocarcinoma by Targeting PARK2 via PTEN/PI3K/AKT Signaling Pathway
10.1007/s10528-021-10084-5 · doi-reference
miR-885-5p inhibits proliferation and metastasis by targeting IGF2BP1 and GALNT3 in human intrahepatic cholangiocarcinoma
10.1002/mc.23262 · doi-reference
miR-204 inhibits epithelial to mesenchymal transition by targeting slug in intrahepatic cholangiocarcinoma cells
10.1159/000354531 · doi-reference
MiR-19b-3p facilitates the proliferation and epithelial-mesenchymal transition, and inhibits the apoptosis of intrahepatic cholangiocarcinoma by suppressing coiled-coil domain containing 6
10.1016/j.abb.2020.108367 · doi-reference
MicroRNA-101 inhibits the migration and invasion of intrahepatic cholangiocarcinoma cells via direct suppression of vascular endothelial growth factor-C
10.3892/mmr.2015.4239 · doi-reference
Forkhead box protein C2 contributes to invasion and metastasis of extrahepatic cholangiocarcinoma, resulting in a poor prognosis
10.1111/cas.12249 · doi-reference
COUP-TFII promotes metastasis and epithelial-to-mesenchymal transition through upregulating Snail in human intrahepatic cholangiocarcinoma
10.1093/abbs/gmaa117 · doi-reference
Enhancer of zeste homolog 2 (EZH2) promotes progression of cholangiocarcinoma cells by regulating cell cycle and apoptosis
10.1245/s10434-013-3135-y · doi-reference
Dicer promotes tumorigenesis by translocating to nucleus to promote SFRP1 promoter methylation in cholangiocarcinoma cells
10.1038/cddis.2017.57 · doi-reference
Silencing of CXCR4 inhibits tumor cell proliferation and neural invasion in human hilar cholangiocarcinoma
10.5009/gnl.2014.8.2.196 · doi-reference
CD90 expression in human intrahepatic cholangiocarcinoma is associated with lymph node metastasis and poor prognosis
10.1002/jso.25192 · doi-reference
Therapeutic effects of deleting cancer-associated fibroblasts in cholangiocarcinoma
10.1158/0008-5472.can-12-2130 · doi-reference
The multi-kinase inhibitor tinengotinib as monotherapy or combined with atezolizumab in advanced solid tumors: a phase Ib/II trial
10.1038/s41467-026-72541-2 · doi-reference
Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial
10.1016/s1470-2045(15)00139-4 · doi-reference
Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study
10.1016/s1470-2045(11)70301-1 · doi-reference
Lymphatic endothelial cells, tumor lymphangiogenesis and metastasis: New insights into intratumoral and peritumoral lymphatics
10.1007/s10555-006-9026-y · doi-reference